{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:31:42Z","timestamp":1783607502646,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Coronavirus disease 19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is affecting the world with a surge in cases. A variety of autoimmune diseases occur after SARS-CoV-2 infection or vaccination, of which IgG4-related disease (IgG4-RD) is an important type. IgG4-RD can involve multiple organs of the body. The ocular manifestation of IgG4-RD is called IgG4-related ophthalmic disease (IgG4-ROD). We herein report a patient diagnosed with IgG4-ROD. The patient developed ptosis and vision loss after SARS-CoV-2 vaccination, and the symptoms worsened after SARS-CoV-2 infection. After excluding other diseases like myasthenia gravis and Eaton-Lambert syndrome that may cause ptosis, the diagnosis of IgG4-ROD was confirmed by pathological examination. We discussed the predisposing factors, diagnosis and treatment of this patient to provide a more empirical and theoretical basis for clinical diagnosis and treatment. We conducted a literature review of previously reported cases of IgG4-RD following SARS-CoV-2 infection or vaccination. We retrieved a total of 9 cases, of which 5 developed symptoms after vaccination and 4 after infection. Demographic and clinical characteristics were summarized. In conclusion, our case represents the first case of proven IgG4-ROD after COVID-19 vaccination. We believe that IgG4-ROD and SARS-CoV-2 infection or vaccination are closely related, and the immune system disorder caused by SARS-CoV-2 infection or vaccination may be a key factor in the pathogenesis of IgG4-RD. But for now, there is no direct evidence that there is a causal relationship between SARS-CoV-2 infection or vaccination and IgG4-ROD, which still needs more research and exploration to confirm.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1303589","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T05:45:58Z","timestamp":1708580758000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A case of IgG4-related ophthalmic disease after SARS-CoV-2 vaccination: case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Peixuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2021","journal-title":"J Med Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28864","article-title":"Overview of autoantibodies in COVID-19 convalescents","volume":"95","author":"Dobrowolska","year":"2023","journal-title":"J Med Virol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872683","article-title":"COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: insights from a narrative literature review","volume":"13","author":"Mahroum","year":"2022","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"m1067","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/icu.0000000000000427","article-title":"IgG4-related disease in the eye and ocular adnexa","volume":"28","author":"Derzko-Dzulynsky","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","article-title":"Diagnostic criteria for IgG4-related ophthalmic disease","volume":"59","author":"Goto","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284442","article-title":"Efficacy and safety of intravenous glucocorticoid therapy for IgG4-related ophthalmic disease","volume":"18","author":"Hosohata","year":"2023","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00375.2021","article-title":"Long-term complications of COVID-19","volume":"322","author":"Desai","year":"2022","journal-title":"Am J Physiol-cell P"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: Faraway, so close","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/1040841x.2019.1614904","article-title":"The role of viral infections in the development of autoimmune diseases","volume":"45","author":"Hussein","year":"2019","journal-title":"Crit Rev Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of ocular adverse events with inactivated COVID-19 vaccination in patients in abu dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1756-185x.14863","article-title":"A rare case of IgG4-associated disease caused by COVID-19: Case report and literature review","author":"Xu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.14744\/hf.2022.2022.0019","article-title":"Acute Liver Injury and IgG4-related Autoimmune Pancreatitis following mRNA based COVID-19 vaccination","volume":"3","author":"Patel","year":"2022","journal-title":"Hepatol Forum"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04231-y","article-title":"High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19","volume":"100","author":"Roncati","year":"2020","journal-title":"Ann Hematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1026","article-title":"IgG4 related pleural disease: Recurrent pleural effusion after COVID-19 vaccination","volume":"10","author":"Tasnim","year":"2022","journal-title":"Respirol Case Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1125-22","article-title":"IgG4-related Disease Emerging after COVID-19 mRNA Vaccination","volume":"62","author":"Aochi","year":"2023","journal-title":"Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1634-23","article-title":"Immunoglobulin G4-related hepatopathy after COVID-19 vaccination","volume":"62","author":"Kuno","year":"2023","journal-title":"Intern Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38124","article-title":"Possible ambiguity in interpretation between immunoglobulin G4-related disease (IgG4-RD) and sarcoidosis in a post-COVID-19 pandemic","volume":"15","author":"Gurunathan","year":"2023","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.2121","article-title":"Acute vision loss from igG4-related and bacterial rhinosinusitis after COVID-19","volume":"147","author":"Harb","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"AB36","DOI":"10.1016\/j.gie.2022.04.130","article-title":"Seronegative type I autoimmune pancreatitis with immunoglobulin G4-related disease triggered by the Pfizer-BioNTech COVID-19 vaccine","volume":"95","author":"Rodrigues","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/art.42043","article-title":"CD163+ M2 macrophages promote fibrosis in igG4-related disease via toll-like receptor 7\/interleukin-1 receptor\u2013associated kinase 4\/NF-\u03baB signaling","volume":"74","author":"Chinju","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/v14071415","article-title":"Potential autoimmunity resulting from molecular mimicry between SARS-coV-2 spike and human proteins","volume":"14","author":"Nunez-Castilla","year":"2022","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2022","journal-title":"Sci Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaci.2022.03.034","article-title":"Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease","volume":"150","author":"Munemura","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-018-0377-y","article-title":"Pathogenesis of IgG4-related disease: a critical review","volume":"107","author":"Maehara","year":"2018","journal-title":"Odontology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117420","article-title":"The neurology of IGG4-related disease","volume":"424","author":"Saitakis","year":"2021","journal-title":"J Neurol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"13341","DOI":"10.1038\/s41598-021-92814-8","article-title":"Serum IgG4 levels at diagnosis can predict unfavorable outcomes of untreated patients with IgG4-related disease","volume":"11","author":"Mizushima","year":"2021","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.115985","article-title":"May IgG4-related disease be reactivated by SARS-CoV-2 infection","volume":"60","author":"Kobak","year":"2022","journal-title":"Rheumatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.001","article-title":"Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination","volume":"100","author":"Ayd\u0131n","year":"2021","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001788","article-title":"Cerebral venous sinus thrombosis presenting transient ischemic attack after recovery from COVID-19 with Graves\u2019 disease and IgG4-related ophthalmic disease: a case report","volume":"62","author":"Egashira","year":"2022","journal-title":"Rinsho Shinkeigaku"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.09.012","article-title":"Serum IgG4 level predicts COVID-19 related mortality","volume":"93","author":"Della-Torre","year":"2021","journal-title":"Eur J Intern Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05953-7","article-title":"Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review","volume":"261","author":"Yeo","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081281","article-title":"Retinal vein occlusion after COVID-19 vaccination\u2014A review","volume":"11","author":"Leung","year":"2023","journal-title":"Vaccines"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-01971-2","article-title":"Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine","volume":"41","author":"Bialasiewicz","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1477_21","article-title":"Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report","volume":"69","author":"Endo","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02459-2","article-title":"Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series","volume":"37","author":"Pellegrini","year":"2023","journal-title":"Eye"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1303589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T05:46:11Z","timestamp":1708580771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1303589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2024.1303589"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1303589","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"article-number":"1303589"}}